These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 33158564)

  • 1. Commentary: Ground-glass opacity-dominant lung cancer. Is every R0 wedge resection always a good wedge resection?
    Scarci M; Raveglia F
    J Thorac Cardiovasc Surg; 2022 Jan; 163(1):305-306. PubMed ID: 33158564
    [No Abstract]   [Full Text] [Related]  

  • 2. Objective radiologic analysis of ground-glass opacity aimed at curative limited resection for small peripheral non-small cell lung cancer.
    Nakata M; Sawada S; Yamashita M; Saeki H; Kurita A; Takashima S; Tanemoto K
    J Thorac Cardiovasc Surg; 2005 Jun; 129(6):1226-31. PubMed ID: 15942561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peripheral pure ground-glass opacity: segmentectomy versus wedge resection.
    Luo T; Chen Q; Zeng J; Cai L; Huang X
    J Cardiothorac Surg; 2021 Sep; 16(1):260. PubMed ID: 34521432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surgical outcome of wide wedge resection in poor-risk patients with clinical-N0 non-small cell lung cancer.
    Tsunezuka H; Kato D; Okada S; Furuya T; Shimada J; Inoue M
    Gen Thorac Cardiovasc Surg; 2017 Oct; 65(10):581-586. PubMed ID: 28748318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lung cancer patients showing pure ground-glass opacity on computed tomography are good candidates for wedge resection.
    Nakamura H; Saji H; Ogata A; Saijo T; Okada S; Kato H
    Lung Cancer; 2004 Apr; 44(1):61-8. PubMed ID: 15013584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Appropriate sublobar resection choice for ground glass opacity-dominant clinical stage IA lung adenocarcinoma: wedge resection or segmentectomy.
    Tsutani Y; Miyata Y; Nakayama H; Okumura S; Adachi S; Yoshimura M; Okada M
    Chest; 2014 Jan; 145(1):66-71. PubMed ID: 24551879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical features and prognosis of clinical N0 non-small cell lung cancer exceeding 30 mm.
    Kagimoto A; Tsutani Y; Handa Y; Mimae T; Miyata Y; Okada M
    Jpn J Clin Oncol; 2020 Oct; 50(11):1306-1312. PubMed ID: 32901276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Surgery for stage 1 lung cancer].
    Bonnette P
    Cancer Radiother; 2011 Oct; 15(6-7):518-21. PubMed ID: 21802335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of cancer control between segmentectomy and wedge resection in patients with clinical stage IA non-small cell lung cancer.
    Tsutani Y; Handa Y; Shimada Y; Ito H; Ikeda N; Nakayama H; Yoshimura K; Okada M
    J Thorac Cardiovasc Surg; 2021 Oct; 162(4):1244-1252.e1. PubMed ID: 33213872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Wedge resection for lung cancer].
    Yoshimura M; Tsubota N
    Nihon Geka Gakkai Zasshi; 2001 Jul; 102(7):521-4. PubMed ID: 11505504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Commentary: Is sublobar resection enough for ground-glass opacity-dominant lung adenocarcinoma?
    Zhang Y; Chen H
    J Thorac Cardiovasc Surg; 2022 Jan; 163(1):303-304. PubMed ID: 33158561
    [No Abstract]   [Full Text] [Related]  

  • 12. Limited resection trial for pulmonary ground-glass opacity nodules: case selection based on high-resolution computed tomography-interim results.
    Yoshida J; Ishii G; Hishida T; Aokage K; Tsuboi M; Ito H; Yokose T; Nakayama H; Yamada K; Nagai K
    Jpn J Clin Oncol; 2015 Jul; 45(7):677-81. PubMed ID: 25900903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Sublobar curative resection for non-small-cell lung cancer].
    Bonnette P
    Bull Cancer; 2012 Nov; 99(11):1069-75. PubMed ID: 23092959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term outcomes of wedge resection for pulmonary ground-glass opacity nodules.
    Cho JH; Choi YS; Kim J; Kim HK; Zo JI; Shim YM
    Ann Thorac Surg; 2015 Jan; 99(1):218-22. PubMed ID: 25440277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sublobar Resection Margin Width Does Not Affect Recurrence of Clinical N0 Non-small Cell Lung Cancer Presenting as GGO-Predominant Nodule of 3 cm or Less.
    Moon Y; Lee KY; Moon SW; Park JK
    World J Surg; 2017 Feb; 41(2):472-479. PubMed ID: 27718002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Limited resection for early-stage non-small cell lung cancer as function-preserving radical surgery: a review.
    Aokage K; Yoshida J; Hishida T; Tsuboi M; Saji H; Okada M; Suzuki K; Watanabe S; Asamura H
    Jpn J Clin Oncol; 2017 Jan; 47(1):7-11. PubMed ID: 27765813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Video-assisted thoracic surgery for pure ground-glass opacities 2 cm or less in diameter.
    Yamada S; Kohno T
    Ann Thorac Surg; 2004 Jun; 77(6):1911-5. PubMed ID: 15172235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic impact of a ground-glass opacity component in clinical stage IA non-small cell lung cancer.
    Hattori A; Suzuki K; Takamochi K; Wakabayashi M; Aokage K; Saji H; Watanabe SI;
    J Thorac Cardiovasc Surg; 2021 Apr; 161(4):1469-1480. PubMed ID: 32451073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ground-glass opacity component in semi-solid lesions: how much is enough?
    Kaiser LR
    Eur J Cardiothorac Surg; 2022 Aug; 62(3):. PubMed ID: 35396985
    [No Abstract]   [Full Text] [Related]  

  • 20. Long-term outcomes of 50 cases of limited-resection trial for pulmonary ground-glass opacity nodules.
    Nakao M; Yoshida J; Goto K; Ishii G; Kawase A; Aokage K; Hishida T; Nishimura M; Nagai K
    J Thorac Oncol; 2012 Oct; 7(10):1563-6. PubMed ID: 22878750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.